Major vessel thrombosis in Behçet's disease: The dilemma of anticoagulant therapy - The approach of rheumatologists from different countries

Clinical and Experimental Rheumatology

Volumn 30, Issue 5, 2012, Pages 735-740

  Tayer Shifman, O E ^a   Seyahi, E ^b   Nowatzky, J ^c   Ben Chetrit, E ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Anticoagulants; Beh et's disease; Thrombosis

Indexed keywords

AZATHIOPRINE; COLCHICINE; ENOXAPARIN; HYDROCORTISONE; PREDNISONE; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BEHCET DISEASE; CASE REPORT; COMPARATIVE STUDY; DRUG MEGADOSE; HUMAN; INTRACARDIAC THROMBOSIS; ISRAEL; LOW DRUG DOSE; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT INDICATION; TURKEY (REPUBLIC); UNITED STATES; VEIN THROMBOSIS;

ADOLESCENT; ADULT; ANTICOAGULANTS; BEHCET SYNDROME; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; HEALTH CARE SURVEYS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISRAEL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PHLEBOGRAPHY; PHYSICIAN'S PRACTICE PATTERNS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TURKEY; UNITED STATES; VENOUS THROMBOSIS;

EID: 84870285426     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. SAKANE T, AKENO M, SUZUKI N, INABA G: Behçet's disease. N Engl J Med 1999;341:1284-91.
2. KOC Y, GULLU I, AKPEK G et al:. Vascular involvement in Behçet's disease. J Rheumatol 1992;19:402-10.
3. CALAMIA KT, SCHIRMER M, MELIKOGLU M: Major vessel involvement in Behçet disease. Curr Opin Rheumatol 2011;23:24-31.
4. IDEGUCHI H, SUDA A, TAKENO M, UEDA A, OHNO S, ISHIGATSUBO Y: Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective color study. Clin Exp Rheumatol 2011;29(Suppl. 67):S47-53.
5. HOUMAN MH, NEFFATI H, BRAHAM A et al.: Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol 2007;25(Suppl. 45):S58-64.
6. AMES PR, STEUER A, PAP A, DENMAN AM: Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology 2001;40:652-5.
7. SARICA-KUCUKOGLU R, AKDAǦ-KOSE A, KAYABALI M et al:. Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases. Int J Dermatol 2006;45:919-21.
8. TOLOSA-VILELLA C, CAPELA CA, MONTEAGUDO-JIMÉNEZ M, MARÍ-ALFONSO B: Infliximab for life-threatening pulmonary artery aneurysms in Behçet's disease. A case report. Clin Exp Rheumatol 2011;29(Suppl. 67):S94-5.
9. CRITERIA FOR DIAGNOSIS OF BEHÇET'S DISEASE: International Study Group for Behçet's Disease. Lancet 1990;335:1078-80.
10. LEIBA M, SELIGSOHN U, SIDI Y et al:. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 2004;63:1445-9.
11. MILLER DV, MALESZEWSKI JJ: The pathology of large-vessel vasculitides. Clin Exp Rheumatol 2011;29(Suppl. 64):S92-8.
12. YAZICI Y, YURDAKUL S, YAZICI H: Behçet's syndrome. Curr Rheumatol Rep 2010;12:429-35.
13. UZUN O, AKPOLAT T, ERKAN L: Pulmonary vasculitis in Behçet disease: a cumulative analysis. Chest 2005;127:2243-53.
14. HATEMI G, SILMAN A, BANG D et al.: EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008;67:1656-62.
15. KAHRAMAN O, CELEBI-ONDER S, KAMALI S et al:. Long-term course of deep venous thrombosis in patients with Behçet's disease. In: Proceedings of the American College of Rheumatology 67th Annual Scientific Meeting, Orlando, Florida. New Jersey, USA: Wiley, 2003; S385.
16. YAZICI H, PAZARLI H, BARNES CG et al.: A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990;322:281-5.
17. AHN JK, LEE YS, JEON CH, KOH EM, CHA HS: Treatment of venous thrombosis associated with Behçet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 2008;27:201-5.
18. MEHTA P, LAFFAN M, HASKARD DO: Thrombosis and Behçet's syndrome in non-endemic regions. Rheumatology 2010;49:2003-4.